Brief: Selvita Receives EUR 1.3 Mln Order From European Biopharmaceutical Company
02/04/2026 07:22
April 2 (Reuters) - Selvita SA SLV1.WA: RECEIVES PURCHASE ORDER FROM EUROPEAN BIOPHARMACEUTICAL COMPANY ORDER EXTENDS COOPERATION WITH CLIENT UNTIL FEBRUARY 28, 2027 ORDER VALUE IS EUR 1.3 MILLION ORDER COVERS DESIGN, SYNTHESIS AND EVALUATION OF NEW CHEMICAL COMPOUNDS Source text: ID:nEM8d0fNva Further company coverage: SLV1.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Selvita SA
See all newsBrief: Selvita Q1 Net Loss At 5.5 Million Zlotys
Brief: Selvita May Consider Delisting Under Strategic Options Review
Brief: Selvita Receives EUR 1.3 Mln Order From European Biopharmaceutical Company
Brief: Selvita Estimates Q1 Consolidated Operating Revenue At 78-82 Mln Zlotys
Brief: Selvita FY Net Profit At 0.8 Million Zlotys